BriaCell Therapeutics Corp.
BCTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001610820
No open-market purchases or sales by BriaCell Therapeutics Corp. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $1.58M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in BriaCell Therapeutics Corp. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- 0 vs. Q1 2023
- Shares held
- 2.78M
- +178.5K (+6.9%) vs. Q1 2023
- Total value
- $17.9M
- −$1.52M (−7.8%) vs. Q1 2023
- New holders
- 5
- 6 more added
- Sold out
- 5
- 5 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BCTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 19 | $1.58M |
| Q1 2026 | 16 | $1.62M |
| Q4 2025 | 13 | $69.2K |
| Q3 2025 | 13 | $136.5K |
| Q2 2025 | 16 | $181.1K |
| Q1 2025 | 14 | $94.1K |
| Q4 2024 | 26 | $379.1K |
| Q3 2024 | 22 | $538.1K |
| Q2 2024 | 20 | $452.0K |
| Q1 2024 | 20 | $6.38M |
| Q4 2023 | 26 | $14.6M |
| Q3 2023 | 21 | $17.0M |
| Q2 2023 | 21 | $17.9M |
| Q1 2023 | 21 | $19.4M |
| Q4 2022 | 21 | $12.3M |
| Q3 2022 | 22 | $14.3M |
| Q2 2022 | 22 | $17.0M |
| Q1 2022 | 18 | $33.5M |
| Q4 2021 | 20 | $10.9M |
| Q3 2021 | 21 | $4.77M |
| Q2 2021 | 24 | $20.3M |
| Q1 2021 | 10 | $1.45M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding BriaCell Therapeutics Corp.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Rosenberg Matthew Hamilton | 12 | $77 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 32 | $205 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 1,127 | $7.24K | 0.00% | +850+306.9% | Added |
| Tower Research Capital LLC (TRC) | 1,389 | $8.92K | 0.00% | −2,798−66.8% | Reduced |
| National Bank of Canada | 2,500 | $15.9K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 3,600 | $23.0K | 0.00% | +3,600 | New |
| Belvedere Trading LLC | 3,688 | $30.7K | 0.01% | +3,688 | New |
| TD Waterhouse Canada Inc. | 12,050 | $90.3K | 0.00% | +12,050 | New |
| Concord Wealth Partners | 15,275 | $98.1K | 0.02% | −2,500−14.1% | Reduced |
| HighTower Advisors, LLC | 16,087 | $104.0K | 0.00% | +1,737+12.1% | Added |
| Susquehanna International Group, LLP | 18,865 | $121.1K | 0.00% | −11,805−38.5% | Reduced |
| K.J. Harrison & Partners Inc | 34,640 | $216.9K | 0.04% | −71,293−67.3% | Reduced |
| Bank of Montreal | 34,629 | $217.4K | 0.00% | +9,483+37.7% | Added |
| Summit Trail Advisors, LLC | 35,000 | $224.7K | 0.01% | 00.0% | Unchanged |
| Simplex Trading, LLC | 39,521 | $253.0K | 0.01% | +38,477+3,685.5% | Added |
| Citadel Advisors LLC | 63,650 | $408.6K | 0.00% | +63,650 | New |
| Morgan Stanley | 75,228 | $483.0K | 0.00% | +4,491+6.3% | Added |
| Natixis | 90,250 | $579.4K | 0.00% | +90,250 | New |
| Redmond Asset Management, LLC | 137,689 | $884.0K | 0.29% | 00.0% | Unchanged |
| Wasatch Advisors Inc | 612,088 | $3.93M | 0.02% | −3,990−0.6% | Reduced |
| Lynwood Capital Management Inc. | 1,583,878 | $10.2M | 12.88% | +53,878+3.5% | Added |
| XTX Topco Ltd | 0 | $0 | 0.00% | −10,383−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −650−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −169−100.0% | Sold out |
| GHP Investment Advisors, Inc. | 0 | $0 | 0.00% | −33−100.0% | Sold out |
| Belpointe Asset Management LLC | 0 | $0 | 0.00% | −15−100.0% | Sold out |